Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001491874-25-000005
Filing Date
2025-10-21
Accepted
2025-10-21 20:52:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2905
  Complete submission text file 0001491874-25-000005.txt   4293
Mailing Address 15 RIORDAN PLACE MENLO PARK CA 94025
Business Address
Parker Geoffrey M. (Reporting) CIK: 0001491874 (see all company filings)

Type: 144

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38693 | Film No.: 251408411
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)